EP. 1: Molecular Testing in Stage III Melanoma
EP. 2: COMBI-AD Trial 5-Year Analysis Data
EP. 3: Checkpoint Blockade Trial Data Updates
EP. 4: KEYNOTE-054 and CheckMate 238 Trial Updates
EP. 5: Ipilimumab Dosing Significance in Adjuvant Setting
EP. 6: COMBI-i Trial Data Updates
EP. 7: Triple Therapy for the Management of Melanoma
EP. 8: Immune Checkpoint Inhibition in Stage IV Melanoma
Oncology Experts Preview Top Abstracts From 2025 ASCO GU
Dr Somaiah on Ongoing Research With Novel Agents in Sarcomas
Dr Hamid on the Potential for Cancer Vaccines in Melanoma
Dr Orloff on Treatment Strategies for Rapidly Progressing Uveal Melanoma